Verification of a novel solid-state electronic glucose sensor

Purpose and goal

The aim of the project was to verify the sensor, intended for glucose monitoring among people with diabetes, being developed by Ascilion. The sensor shows promise to be able to measure glucose without the need for blood or finger pricking as well as offering a pain free measurement method. The goals of the project was fulfilled and Ascilion developed together with the University hospital in Uppsala a method for extraction of interstital fluid, handling of as well as measurements on the fluid. All work was conducted under an ethical approval from the Approval board committee in Uppsala.

Expected results and effects

The results from the project range from ethical approval of interstitial fluid from humans via demonstrated correlation of glucose concentration measured using RF spectroscopy to increased collaboration between industry and healthcare. Expected outcomes are continuous joint development of both the sensor and the product.

Planned approach and implementation

All development work was performed in project form. Innovation Akademiska (IA) did a large part of the coordination although Ascilion was formally the coordinator. There is no question that the good outcome of the project to a large part is due to the help from IA as it quickly can be overwhelming for a small company to collaborate with large hospitals. The project has engaged stakeholders and personnel from Ascilion, the Burn Center, Neonatal Intensive Care, Laboratory Medicine at Uppsala university hospital and The Rudbeck laboratory and The Ångström Laboratory at Uppsala University.